Depression, panic disorder, and PTSD each involve distinct patterns of stress neurohormone dysregulation (CRF, vasopressin, NPY, ANP), with ANP showing anxiolytic properties that could represent a novel treatment target.
Disorder-specific profilesEach stress disorder has its own neurohormone pattern: depression (CRF/vasopressin), panic (distinct CRF), PTSD (NPY/cortisol) — different diseases, different peptide targets
What the researchers found
Depression, panic, and PTSD show distinct stress neurohormone patterns (CRF, vasopressin, NPY alterations), with ANP demonstrating anxiolytic properties — disorder-specific peptide profiles enabling targeted therapy.
Why it matters
Different stress disorders involve different peptide systems. Matching treatment to the specific neurohormonal pattern could dramatically improve psychiatric outcomes.
How the study worked
Review of clinical studies measuring stress neurohormones in depression, panic disorder, and PTSD patients, with emerging data on ANP's anxiolytic effects.
What this study cannot tell us
Review of clinical data with varying study quality. The clinical utility of neurohormonal profiling for treatment selection was not established.
How to read the evidence
Moderate evidence from a review integrating clinical neuroendocrine data across three psychiatric diagnoses.
When this study was published
Published in 2003. The concept of disorder-specific neurohormonal profiles continues to inform precision psychiatry approaches.
The bigger picture
Precision psychiatry should match the drug to the disorder's specific neurochemical profile. This review provides the neurohormonal map for that matching.
Questions still open
- Could ANP or its analogs treat panic disorder?
- Should neurohormone profiles guide psychiatric drug selection?
- Would CRF1 antagonists work differently in depression vs PTSD?
Common questions
Are depression, anxiety, and PTSD the same thing neurochemically?
Can a heart hormone treat anxiety?
Read the original research
Stress responsive neurohormones in depression and anxiety.
Pharmacopsychiatry, 36 Suppl 3, S207-14
Citation
Ströhle, A; Holsboer, F. (2003). Stress responsive neurohormones in depression and anxiety.. Pharmacopsychiatry, 36 Suppl 3, S207-14.